KFSHRC has partnered with the Madinah Diabetes Charity Association, ‘Sukar’, to advance the early detection and treatment of ...

I have been diagnosed with diabetic retinopathy. The doctor recommends intravitreal injections over a few months. It's a ...

Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and ...

There’s a misperception that cancer mostly impacts older people. Not so. Cancer is on the rise in people 50 and under.Actor ...

Over 537 million people globally suffer from diabetes, with 227 million in Asia Pacific. More than half may develop diabetic retinopathy (DR) within 10 years, potentially leading to blindness.

The phase 3 trial showed biosimilar CT-P42 (Celltrion) is therapeutically equivalent to reference aflibercept in improving visual acuity in patients with diabetic macular edema (DME), with comparable ...

Left untreated, type 1, in particular, can lead to diabetic ketoacidosis. This is when there is a dangerous level ... Insulin is the main treatment for type 1 and 1.5 diabetes.

Though having prediabetes doesn’t mean you are about to develop diabetes, it’s a good idea ... This helps prevent blood sugar spikes. Treatment usually involves use of an oral appliance ...

More than one million patients in England were unable to contact their GP at all throughout December 2024 Credit: Sturti ...

Valo Health’s Rho kinase (ROCK) 1 and 2 inhibitor has failed to reduce the severity of diabetic retinopathy in a phase 2 trial, leading the Flagship-founded biotech to drop the candidate.